As of 2026-03-25, the EV/EBITDA ratio of STAAR Surgical Co (STAA) is -22.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STAA's latest enterprise value is 790.42 mil USD. STAA's TTM EBITDA according to its financial statements is -34.56 mil USD. Dividing these 2 quantities gives us the above STAA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 14.7x | 13.5x |
| Forward P/E multiples | 12.2x - 15.7x | 13.8x |
| Fair Price | (5.65) - (7.12) | (6.42) |
| Upside | -129.8% - -137.5% | -133.9% |
| Date | EV/EBITDA |
| 2026-03-24 | -22.87 |
| 2026-03-23 | -22.21 |
| 2026-03-20 | -20.79 |
| 2026-03-19 | -20.71 |
| 2026-03-18 | -22.31 |
| 2026-03-17 | -21.26 |
| 2026-03-16 | -21.59 |
| 2026-03-13 | -22.69 |
| 2026-03-12 | -22.04 |
| 2026-03-11 | -20.99 |
| 2026-03-10 | -20.37 |
| 2026-03-09 | -21.94 |
| 2026-03-06 | -22.14 |
| 2026-03-05 | -22.30 |
| 2026-03-04 | -23.23 |
| 2026-03-03 | -22.80 |
| 2026-03-02 | -22.99 |
| 2026-02-27 | -24.21 |
| 2026-02-26 | -24.82 |
| 2026-02-25 | -24.54 |
| 2026-02-24 | -24.00 |
| 2026-02-23 | -21.77 |
| 2026-02-20 | -21.13 |
| 2026-02-19 | -21.30 |
| 2026-02-18 | -20.84 |
| 2026-02-17 | -18.89 |
| 2026-02-13 | -18.74 |
| 2026-02-12 | -19.30 |
| 2026-02-11 | -20.40 |
| 2026-02-10 | -20.47 |
| 2026-02-09 | -20.63 |
| 2026-02-06 | -20.87 |
| 2026-02-05 | -20.14 |
| 2026-02-04 | -20.82 |
| 2026-02-03 | -21.69 |
| 2026-02-02 | -21.53 |
| 2026-01-30 | -22.84 |
| 2026-01-29 | -22.83 |
| 2026-01-28 | -23.13 |
| 2026-01-27 | -22.97 |
| 2026-01-26 | -23.08 |
| 2026-01-23 | -23.12 |
| 2026-01-22 | -24.20 |
| 2026-01-21 | -25.23 |
| 2026-01-20 | -25.75 |
| 2026-01-16 | -25.75 |
| 2026-01-15 | -25.75 |
| 2026-01-14 | -26.98 |
| 2026-01-13 | -25.98 |
| 2026-01-12 | -27.25 |